Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124756455 | 12475645 | 5 | F | 20160201 | 20160809 | 20160617 | 20160823 | EXP | JP-009507513-1606JPN006566 | MERCK | 69.00 | YR | M | Y | 60.00000 | KG | 20160823 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124756455 | 12475645 | 1 | PS | TEMODAL | TEMOZOLOMIDE | 1 | Oral | 75 MG/M2, DAILY, DIVIDED DOSE, FREQUENCY UNKNOWN | 3300 | MG/M2 | 21029 | 75 | MG/M**2 | CAPSULE | QD | ||||
| 124756455 | 12475645 | 2 | SS | E KEPPRA | LEVETIRACETAM | 1 | Oral | 500 MG, TWICE DAILY | 84000 | MG | Y | 0 | 500 | MG | TABLET | BID | |||
| 124756455 | 12475645 | 3 | SS | BAKTAR | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 1 DOSAGE FORM, TWICE DAILY | Y | 0 | 1 | DF | TABLET | BID | |||||
| 124756455 | 12475645 | 4 | SS | NASEA | RAMOSETRON HYDROCHLORIDE | 1 | Oral | 0.1 MG, ONCE DAILY | 4 | MG | 0 | .1 | MG | TABLET | QD | ||||
| 124756455 | 12475645 | 5 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 15 MG, ONCE DAILY | 765 | MG | Y | 0 | 15 | MG | TABLET | QD | |||
| 124756455 | 12475645 | 6 | SS | HERBAL NOS | HERBALS | 1 | Oral | 2.5 G, TID | 368 | G | 0 | 2.5 | G | GRANULES | TID | ||||
| 124756455 | 12475645 | 7 | C | REMERON | MIRTAZAPINE | 1 | Oral | 15 MG, QD | 0 | 15 | MG | TABLET | QD | ||||||
| 124756455 | 12475645 | 8 | C | ZYPREXA | OLANZAPINE | 1 | Oral | 2.5 MG, ONCE A DAY | 0 | 2.5 | MG | TABLET | QD | ||||||
| 124756455 | 12475645 | 9 | C | ONCOVIN | VINCRISTINE SULFATE | 1 | Parenteral | 1 MG, BID | 0 | 1 | MG | INJECTION | BID | ||||||
| 124756455 | 12475645 | 10 | C | INTERFERON BETA NOS | INTERFERON BETA | 1 | Parenteral | DAILY DOSAGE UNKNOWN | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124756455 | 12475645 | 1 | Malignant glioma |
| 124756455 | 12475645 | 2 | Prophylaxis |
| 124756455 | 12475645 | 3 | Prophylaxis |
| 124756455 | 12475645 | 4 | Prophylaxis |
| 124756455 | 12475645 | 5 | Prophylaxis |
| 124756455 | 12475645 | 6 | Decreased appetite |
| 124756455 | 12475645 | 7 | Depression |
| 124756455 | 12475645 | 8 | Restlessness |
| 124756455 | 12475645 | 9 | Malignant glioma |
| 124756455 | 12475645 | 10 | Malignant glioma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124756455 | 12475645 | OT |
| 124756455 | 12475645 | HO |
| 124756455 | 12475645 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124756455 | 12475645 | Affective disorder | |
| 124756455 | 12475645 | Aplasia pure red cell | |
| 124756455 | 12475645 | Decreased appetite | |
| 124756455 | 12475645 | Depression | |
| 124756455 | 12475645 | Malaise | |
| 124756455 | 12475645 | Nausea | |
| 124756455 | 12475645 | Pancytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124756455 | 12475645 | 1 | 20160114 | 20160226 | 0 | |
| 124756455 | 12475645 | 2 | 20151211 | 20160315 | 0 | |
| 124756455 | 12475645 | 3 | 20160113 | 2016 | 0 | |
| 124756455 | 12475645 | 4 | 20160113 | 20160226 | 0 | |
| 124756455 | 12475645 | 5 | 20160113 | 20160323 | 0 | |
| 124756455 | 12475645 | 6 | 20160114 | 20160302 | 0 | |
| 124756455 | 12475645 | 7 | 20160307 | 20160425 | 0 | |
| 124756455 | 12475645 | 8 | 20160307 | 20160430 | 0 |